[Clinical observation on six children of left bundle branch area pacing]

C C Dai1, W L Dai2, B J Guo1

  • 1Department of Pediatric Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China.

Insights

Left bundle branch area pacing (LBBAP) is safe and effective in children, improving cardiac function and reducing left ventricular enlargement. This pediatric pacing method offers physiological benefits with stable parameters and quick recovery.

Area of Science:

  • Pediatric Cardiology
  • Electrophysiology
  • Cardiac Pacing

Background:

  • Right ventricular apical pacing (RVAP) can lead to cardiac dysfunction and enlargement in children.
  • Alternative pacing strategies are needed to achieve more physiological cardiac pacing in pediatric patients.
  • Left bundle branch area pacing (LBBAP) is an emerging technique for cardiac pacing.

Purpose of the Study:

  • To evaluate the safety and effectiveness of left bundle branch area pacing (LBBAP) in pediatric patients.
  • To assess the impact of LBBAP on cardiac function, left ventricular dimensions, and pacing parameters in children.

Main Methods:

  • Retrospective analysis of 6 pediatric patients (9-14 years) who underwent permanent pacemaker implantation with LBBAP.
  • Evaluation of clinical data, pacing electrocardiograms, and echocardiographic parameters before and after LBBAP.
  • Assessment of pacing thresholds, sensing thresholds, impedance, and QRS duration.

Main Results:

  • LBBAP achieved narrow QRS pacing with stable parameters (pacing threshold: 0.85±0.26 V, sensing: 15.0±4.3 mV, impedance: 717±72 Ω).
  • No significant difference in QRS duration was observed post-LBBAP compared to pre-operation.
  • LBBAP improved cardiac function in a patient with pre-existing dysfunction and reduced left ventricular end-diastolic diameter (LVEDD) Z-score (1.85±0.65 to 1.1±0.3).

Conclusions:

  • Left bundle branch area pacing (LBBAP) is a safe and feasible pacing strategy for children, offering physiological benefits.
  • LBBAP effectively improves cardiac dysfunction and reduces left ventricular enlargement associated with bradycardia or RVAP.
  • Further long-term studies are needed to fully understand the potential risks of LBBAP in the pediatric population.